The coordinated buying by large passive managers suggests strong underlying demand, possibly due to index inclusion, ETF flows, or rebalancing. Traders should monitor for follow-through buying and potential upward pressure on price, especially given absence of institutional selling.
EXEL drugs
EXEL drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 2 $40.98entry
- T+1 · 9mo ago −0.98%α −0.06% · $40.58
- T+5 · 8mo ago +3.34%α +4.55% · $42.35
- T+20 · 8mo ago +2.32%α +10.26% · $41.93
- T+60 · 6mo ago +21.97%α +12.64% · $49.98
How similar events traded
Executive Summary
Three major passive institutional investors, Morgan Stanley, Wells Fargo, and UBS, significantly increased their positions in Exelixis (EXEL) during Q4 2024, collectively adding $77.7 million in new exposure with no notable selling. The largest move was Wells Fargo doubling down, increasing its stake by over 1600% in value.
Key Financial Metrics
Institutional Positions
Net institutional flow: $77.7M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | ADD | +29.1% | $91.7M | $36.3M |
| Wells Fargo | DOUBLED | +1637.9% | $24.9M | $23.7M |
| UBS | ADD | +69.6% | $32.6M | $17.6M |
Key Facts
- Morgan Stanley increased EXEL holdings by $36.3M (29.1% share increase)
- Wells Fargo DOUBLED down, adding $23.7M (1637.9% share increase)
- UBS added $17.6M (69.6% share increase)
- No institutional selling observed in this quarter
- Total net buying: $77.7M across 3 mega-passive institutions
Financial Impact
3 institutions accumulated $77.7M in new positions with no selling, indicating strong passive inflow
Risk Factors
- All buyers are passive managers, suggesting the move may reflect mechanical rebalancing rather than fundamental conviction
- Recent insider selling ($2.1M in past 30 days) contrasts with institutional buying
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-EXEL-2024-Q4 |
Track record
16 reports on EXEL
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 9, 20267d ago SC 13G Neutral 3/10 Entry $70.58 to $70.70 ▲ +0.17% −1.15% vs SPY
- Nov 9, 20267d ago SC 13D/A Bearish 5/10 Entry $70.58 to $70.70 ▼ −0.17% +1.15% vs SPY
- Oct 29, 202618d ago 8-K Neutral 5/10 Entry $69.39 to $70.13 ▲ +1.07% +1.55% vs SPY
- Oct 20, 202627d ago Institutional Cluster Neutral 2/10 Entry $64.58 to $65.31 ▲ +1.13% +2.31% vs SPY
- Oct 12, 20265w ago Institutional Cluster Neutral 3/10 Entry $59.82 to $59.51 ▼ −0.52% −0.51% vs SPY
- Sep 11, 20269w ago 8-K Bearish 6/10 Entry $56.12 to $56.21 ▼ −0.16% −0.61% vs SPY
- Jun 3, 202623w ago Insider Cluster Neutral 2/10 Entry $52.39 to $52.69 ▲ +0.57% +3.17% vs SPY
- May 29, 202624w ago 8-K Neutral 3/10 Entry $50.20 to $48.49 ▼ −3.41% −3.55% vs SPY
- May 28, 202624w ago Insider Cluster Neutral 3/10 Entry $50.32 to $50.28 ▼ −0.08% −0.35% vs SPY
- May 28, 202624w ago Insider Cluster Neutral 3/10 Entry $50.32 to $50.28 ▼ −0.08% −0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers